These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 8819585)
101. Relative Principal Components Analysis: Application to Analyzing Biomolecular Conformational Changes. Ahmad M; Helms V; Kalinina OV; Lengauer T J Chem Theory Comput; 2019 Apr; 15(4):2166-2178. PubMed ID: 30763093 [TBL] [Abstract][Full Text] [Related]
102. Abstracts presented at the XII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications. 10-14 June 2003, Los Cabos, Mexico. Antivir Ther; 2003 Jun; 8(3):S1-170. PubMed ID: 14703650 [No Abstract] [Full Text] [Related]
103. Editorial: HIV and Antiretroviral Drugs: Current Status and New Challenges. Nikolopoulos G; Bonovas S Curr Pharm Des; 2017; 23(18):2551. PubMed ID: 28425865 [No Abstract] [Full Text] [Related]
107. How drug resistance arises. Richman DD Sci Am; 1998 Jul; 279(1):88. PubMed ID: 9648301 [No Abstract] [Full Text] [Related]
108. Editorial: Extra-Cellular Factors as New Anti-HIV Therapeutic Target. Federico M Curr Drug Targets; 2016; 17(1):3. PubMed ID: 26687603 [No Abstract] [Full Text] [Related]
109. Strategies to inhibit viral polyprotein cleavages. Korant BD Ann N Y Acad Sci; 1990; 616():252-7. PubMed ID: 2078022 [No Abstract] [Full Text] [Related]
110. In pursuit of a cure. Jefferys R IAVI Rep; 2012; 16(1):12-6. PubMed ID: 22442882 [No Abstract] [Full Text] [Related]
111. Probe detects HIV protease and toxicity of drugs. AIDS Patient Care STDS; 2010 Nov; 24(11):744. PubMed ID: 21067358 [No Abstract] [Full Text] [Related]
112. Signal processing for functional analysis of protein mutants. Najarian K; Gopalakrishnan K; Zadeh RH Int J Bioinform Res Appl; 2005; 1(1):102-20. PubMed ID: 18048124 [TBL] [Abstract][Full Text] [Related]
113. HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity. Monini P; Sgadari C; Barillari G; Ensoli B J Antimicrob Chemother; 2003 Feb; 51(2):207-11. PubMed ID: 12562682 [No Abstract] [Full Text] [Related]
115. Computer-assisted drug design. Part I. Conditions in the 1980s. Snyder JP Med Res Rev; 1991 Nov; 11(6):641-62. PubMed ID: 1762475 [No Abstract] [Full Text] [Related]
116. HIV protease inhibitors and atherosclerosis. Hui DY J Clin Invest; 2003 Feb; 111(3):317-8. PubMed ID: 12569155 [No Abstract] [Full Text] [Related]
117. HIV protease inhibitors and nuclear lamin processing: getting the right bells and whistles. Clarke SG Proc Natl Acad Sci U S A; 2007 Aug; 104(35):13857-8. PubMed ID: 17709742 [No Abstract] [Full Text] [Related]
118. HIV-1 protease inhibitors may interfere with the ubiquitous intracellular proteases. Visnegarwala F; Musher DM; White AC Ann Intern Med; 2001 Nov; 135(9):840. PubMed ID: 11694112 [No Abstract] [Full Text] [Related]
119. Opportunities and challenges in new HIV therapeutic discovery: what is the next step? Xu S; Sun L; Liu X; Zhan P Expert Opin Drug Discov; 2023; 18(11):1195-1199. PubMed ID: 37561085 [No Abstract] [Full Text] [Related]
120. Protein containers--promising tools for the future. Lalli M; Facey SJ; Hauer B Chembiochem; 2011 Jul; 12(10):1519-21. PubMed ID: 21630410 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]